Drug Trial Radar · NCT03237936
Effect of IKERVIS® Eye Drops Once Daily on the Quality of Vision in Dry Eye Disease Patients With Severe Keratitis
Last checked: Nov 20, 2026Latest source record: Apr 18, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
17
Actual
Start
Mar 28, 2017
Primary completion
Jul 11, 2018
Study completion Jul 11, 2018
Sponsor
- Lead sponsor
- Santen SASIndustry
- Sponsor type
- Industry
- First posted
- Aug 3, 2017
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The proposed 3-month study is a prospective, open-label, multicentre, phase IV, proof of concept study. The study is designed to assess the effect on the quality of vision of IKERVIS® (1mg/mL ciclosporin) eye drops administered once daily in dry eye disease (DED) patients with severe keratitis, as well as its safety and efficacy.
Conditions
- Keratitis
Interventions
1mg/mL ciclosporinDrug
IKERVIS® (1mg/ml ciclosporin) eye drops administered once daily following 3 months of treatment
Primary outcomes
What the sponsor says the trial is designed to measure.
- Correlation Between the Change From Baseline in VMR Measured With FVA System at Month 3 and the Change From Baseline in the CFS at Month 3.Time frame: at month 3
Locations
1 site in 1 country. Site status is shown where the registry gives one.
CHU de Brest
Brest, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.